Childhood acute lymphoblastic leukemia: genetic determinants of susceptibility and disease outcome (Q34663997)

3 August 2017

1 reference

title

Childhood acute lymphoblastic leukemia: genetic determinants of susceptibility and disease outcome (English)

1 reference

3 August 2017

1 reference

lymphoblastic leukemia

1 reference

Krajinovic M

1

1 reference

3 August 2017

Labuda D

series ordinal

2

1 reference

3 August 2017

Sinnett D

series ordinal

3

1 reference

3 August 2017

publication date

1 July 2001

1 reference

Reviews on Environmental Health

3 August 2017

published in

1 reference

3 August 2017

volume

16

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

263-279

1 reference

Acute lymphoblastic leukemia in children

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2001.16.4.263

Environment and cancer: who are susceptible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2001.16.4.263

Pesticides and childhood cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2001.16.4.263

Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2001.16.4.263

Molecular mechanisms of genetic polymorphisms of drug metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2001.16.4.263

Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2001.16.4.263

Genetic metabolic polymorphisms and the risk of cancer: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2001.16.4.263

Myeloperoxidase-enhanced formation of (+-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene-DNA adducts in lung tissue in vitro: a role of pulmonary inflammation in the bioactivation of a procarcinogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2001.16.4.263

An Alu element in the myeloperoxidase promoter contains a composite SP1-thyroid hormone-retinoic acid response element

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2001.16.4.263

Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2001.16.4.263

Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2001.16.4.263

The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2001.16.4.263

Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2001.16.4.263

Theta class glutathione S-transferase GSTT1 genotypes and susceptibility to cervical neoplasia: interactions with GSTM1, CYP2D6 and smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2001.16.4.263

Susceptibility to multiple cutaneous basal cell carcinomas: significant interactions between glutathione S-transferase GSTM1 genotypes, skin type and male gender

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2001.16.4.263

Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2001.16.4.263

Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2001.16.4.263

Genetic polymorphism of N-acetyltransferase-2, glutathione S-transferase-M1, and cytochromes P450IIE1 and P450IID6 in the susceptibility to head and neck cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2001.16.4.263

Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2001.16.4.263

Characterization of a polymorphism in NAD(P)H: quinone oxidoreductase (DT-diaphorase).

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2001.16.4.263

Role of NQO1, MPO and CYP2E1 genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2001.16.4.263

Genetic susceptibility to childhood acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2001.16.4.263

Association mapping in structured populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2001.16.4.263

Expression of CYP2E1 in human lung and kidney during development and in full-term placenta: a differential methylation of the gene is involved in the regulation process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2001.16.4.263

Individualization of cancer therapy based on cytochrome P450 polymorphism: a pharmacogenetic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2001.16.4.263

The role of NAD(P)H oxidoreductase (DT-Diaphorase) in the bioactivation of quinone-containing antitumor agents: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2001.16.4.263

A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2001.16.4.263

Free radical formation by antitumor quinones

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVEH.2001.16.4.263

10.1515/REVEH.2001.16.4.263

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference